We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Paracetamol should be taken as directed in the patient information leaflet
New jobs to strengthen innovation, safety and smarter regulation across the UK health and life sciences sector.
Ensuring the seasonal flu vaccine is ready, safe and effective involves months of international planning, testing and collaboration
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 15 July 2025, approved sebetralstat (Ekterly) for the treatment of hereditary angioedema (HAE) attacks in adults and adolescents aged 12 years and old…
The specifications will establish standards for high-risk diagnostic tests while creating consistency with European regulations
The new Business Plan sets out priorities for 2025–26: Protecting public safety and maintaining public trust; delivering efficient, predictable services through regulatory excellence; being an agile organisation that drives …
New MHRA CEO puts safety, accelerated access and innovation at the centre of agency’s refreshed strategic direction.
New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor the safety and performance of their products once on the market.
Anyone who suspects that they’ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should report it to the MHRA.
The meeting, which took place at the Royal College of Surgeons in Edinburgh, centred on the MHRA’s commitment to delivering the agency’s priorities in Scotland
As with all products, we will keep its safety under close review
Mental health apps are everywhere, offering everything from mood tracking to therapy. But with so many options, how can people tell what these tools actually do?
As with all medicines, the MHRA will continue to monitor the safety and effectiveness of Trixeo Aerosphere
The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding patients with asthma of the importance of using their preventer (anti-inflammatory) inhaler regularly as prescribed, and to avoid relying on their b…
The appointment will involve a time commitment of 22 days per year. Remuneration for the role will be at a rate of £325 per attendance and preparation for meetings.
The World Health Organization (WHO) has confirmed the successful redesignation of the Medicines and Healthcare products Regulatory Agency (MHRA)’s Science and Research group as one of its Collaborating Centres for the Standa…
Seven new CERSIs came together to showcase how partnerships will modernise regulation in AI, clinical trials, and advanced therapies, bringing innovations to patients sooner.
New guidance helps manufacturers navigate medical device regulations and protect users of digital mental health technologies.
Fresh guidance will give businesses the green light to sell certain pioneering hearing aids.
A suite of guidance has been published by the Medicines and Healthcare products Regulatory Agency (MHRA).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).